Figure 4

Impact of fenofibrate administration for 4 weeks on brain UCP2 modulation, NF-κB protein expression, oxidative stress level in JD-fed SHRSP. (a and b) UCP2 gene and protein expression levels; (c) NF-κB expression level; (d and e) oxidative stress level; n=4 for each experimental group. ***P<0.0001 for each comparison